Impact of regulatory polymorphisms in organic anion transporter genes in the human liver
- PMID: 19620935
- DOI: 10.1097/FPC.0b013e32832fabd3
Impact of regulatory polymorphisms in organic anion transporter genes in the human liver
Abstract
Objectives: The aim of this study was to evaluate whether genetic polymorphisms are responsible for individual variation in the expression levels of hepatic organic anion transporters.
Methods: The mRNA levels of multidrug resistance-associated protein 2, organic anion transporting polypeptide (OATP) 1B1, OATP1B3 and OATP2B1 were determined by real-time polymerase chain reaction using liver tissue samples from 102 Japanese. The association between the mRNA levels of these transporters and the disappearance rate of indocyanine green was examined. The promoter region of each transporter gene was sequenced and the effects of single nucleotide polymorphisms (SNPs) in the promoter region [regulatory SNPs (rSNPs)] on mRNA levels were evaluated. Western blot analysis using hepatic crude plasma membrane was carried out to assess protein levels.
Results: Expression levels of hepatic organic anion transporters vary considerably among individuals and possible links were observed between mRNA levels of these transporters and the disappearance rate of indocyanine green. In the OATP2B1 promoter region, we identified an rSNP (-282G > A) that significantly increased mRNA expression. Western blot analysis showed a remarkable increase in the OATP2B1 protein level in the homozygotes for the rSNP with a high mRNA level. In contrast, none of the rSNPs of multidrug resistance-associated protein 2, OATP1B1 and OATP1B3 affected the mRNA expression.
Conclusion: OATP2B1 -282G > A is a major factor affecting expression, suggesting a contribution to inter-individual differences in the expression level of OATP2B1.
Similar articles
-
Hepatocyte nuclear factor 1 alpha is a factor responsible for the interindividual variation of OATP1B1 mRNA levels in adult Japanese livers.Pharm Res. 2007 Dec;24(12):2327-32. doi: 10.1007/s11095-007-9458-2. Epub 2007 Oct 12. Pharm Res. 2007. PMID: 17932728
-
Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.Pharmacogenet Genomics. 2006 Nov;16(11):801-8. doi: 10.1097/01.fpc.0000230422.50962.91. Pharmacogenet Genomics. 2006. PMID: 17047488
-
Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1.Pharmacogenet Genomics. 2008 Jul;18(7):559-68. doi: 10.1097/FPC.0b013e3282fe9a2c. Pharmacogenet Genomics. 2008. PMID: 18551036 Clinical Trial.
-
Genetic polymorphisms of OATP transporters and their impact on intestinal absorption and hepatic disposition of drugs.Drug Metab Pharmacokinet. 2012;27(1):106-21. doi: 10.2133/dmpk.dmpk-11-rv-099. Epub 2011 Dec 20. Drug Metab Pharmacokinet. 2012. PMID: 22185815 Review.
-
Impact of genetic variation in OATP transporters to drug disposition and response.Drug Metab Pharmacokinet. 2013;28(1):4-18. doi: 10.2133/dmpk.dmpk-12-rv-099. Epub 2012 Oct 9. Drug Metab Pharmacokinet. 2013. PMID: 23047721 Review.
Cited by
-
Interindividual Diversity in Expression of Organic Anion Uptake Transporters in Normal and Cirrhotic Human Liver.Hepatol Commun. 2020 Mar 11;4(5):739-752. doi: 10.1002/hep4.1489. eCollection 2020 May. Hepatol Commun. 2020. PMID: 32363323 Free PMC article.
-
e-PKGene: a knowledge-based research tool for analysing the impact of genetics on drug exposure.Hum Genomics. 2011 Jul;5(5):506-15. doi: 10.1186/1479-7364-5-5-506. Hum Genomics. 2011. PMID: 21807605 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources